deltatrials
Completed NA INTERVENTIONAL 2-arm NCT02660411

Impact of Anesthesia Maintenance Methods on Long-term Survival

Impact of Inhalational Versus Intravenous Anesthesia Maintenance Methods on Long-term Survival in Elderly Patients After Cancer Surgery: a Randomized Controlled Trial

Sponsor: Affiliated Hospital of Qinghai University

Conditions Aged Anesthesia, Inhalation Anesthesia, Intravenous Neoplasms Surgical Procedure, Operative Survival
Interventions Propofol Sevoflurane
Updated 17 times since 2017 Last updated: Mar 1, 2022 Started: Apr 1, 2015 Primary completion: Sep 29, 2017 Completion: Sep 30, 2020
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

Listed as NCT02660411, this NA trial focuses on Aged and Anesthesia, Inhalation and remains completed. Sponsored by Affiliated Hospital of Qinghai University, it has been updated 17 times since 2015, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.

Status Flow

~Jan 2017 – ~Jun 2017 · 5 months · monthly snapshot~Jun 2017 – ~Jul 2017 · 30 days · monthly snapshot~Jul 2017 – ~Oct 2017 · 3 months · monthly snapshot~Oct 2017 – ~Dec 2017 · 2 months · monthly snapshot~Dec 2017 – ~Jun 2018 · 6 months · monthly snapshot~Jun 2018 – ~Jan 2019 · 7 months · monthly snapshot~Jan 2019 – ~Jan 2020 · 12 months · monthly snapshot~Jan 2020 – ~Jan 2021 · 12 months · monthly snapshot~Jan 2021 – ~Feb 2021 · 31 days · monthly snapshot~Feb 2021 – ~Mar 2021 · 28 days · monthly snapshot~Mar 2021 – ~May 2021 · 2 months · monthly snapshot~May 2021 – ~Sep 2021 · 4 months · monthly snapshot~Sep 2021 – ~Mar 2022 · 6 months · monthly snapshot~Mar 2022 – ~Apr 2022 · 31 days · monthly snapshot~Apr 2022 – ~Jul 2024 · 27 months · monthly snapshot~Jul 2024 – ~Sep 2024 · 2 months · monthly snapshot~Sep 2024 – present · 22 months · monthly snapshot

Change History

17 versions recorded

  1. Sep 2024 — Present [monthly]

    Completed NA

  2. Jul 2024 — Sep 2024 [monthly]

    Completed NA

  3. Apr 2022 — Jul 2024 [monthly]

    Completed NA

  4. Mar 2022 — Apr 2022 [monthly]

    Completed NA

  5. Sep 2021 — Mar 2022 [monthly]

    Completed NA

▶ Show 12 earlier versions

  1. May 2021 — Sep 2021 [monthly]

    Completed NA

    Phase: PHASE4 → NA

  2. Mar 2021 — May 2021 [monthly]

    Completed PHASE4

  3. Feb 2021 — Mar 2021 [monthly]

    Completed PHASE4

    Status: Active Not Recruiting → Completed

  4. Jan 2021 — Feb 2021 [monthly]

    Active Not Recruiting PHASE4

  5. Jan 2020 — Jan 2021 [monthly]

    Active Not Recruiting PHASE4

  6. Jan 2019 — Jan 2020 [monthly]

    Active Not Recruiting PHASE4

  7. Jun 2018 — Jan 2019 [monthly]

    Active Not Recruiting PHASE4

  8. Dec 2017 — Jun 2018 [monthly]

    Active Not Recruiting PHASE4

    Status: Recruiting → Active Not Recruiting

  9. Oct 2017 — Dec 2017 [monthly]

    Recruiting PHASE4

  10. Jul 2017 — Oct 2017 [monthly]

    Recruiting PHASE4

  11. Jun 2017 — Jul 2017 [monthly]

    Recruiting PHASE4

  12. Jan 2017 — Jun 2017 [monthly]

    Recruiting PHASE4

    First recorded

Apr 2015

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:
  • Affiliated Hospital of Qinghai University
  • Beijing Shijitan Hospital, Capital Medical University
  • Cancer Hospital of Guangxi Medical University
  • Guizhou Provincial People's Hospital
  • Hebei Medical University Fourth Hospital
  • Peking University First Hospital
  • Shanxi Provincial People's Hospital
  • Shenzhen Second People's Hospital
  • Tang-Du Hospital
  • The First Affiliated Hospital of Zhengzhou University
  • The People's Hospital of Ningxia
  • The Third Xiangya Hospital of Central South University
  • Tianjin Nankai Hospital
  • Zhongda Hospital
Data source: Peking University First Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

Beijing, China , Changsha, China , Guiyang, China , Nanjing, China , Nanning, China , Shenzhen, China , Shijiazhuang, China , Taiyuan, China , Tianjin, China , Xi'an, China and 3 more locations